Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients

Alexandra T. Strauss; Andrew M. Hallett; Brian J. Boyarsky; Michael T. Ou; William A. Werbel; Robin K. Avery; Aaron A.R. Tobian; Allan B. Massie; James P.A. Hamilton; Jacqueline M. Garonzik-Wang; Dorry L. Segev

doi:10.1002/lt.26273

Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients

Alexandra T. Strauss, Andrew M. Hallett, Brian J. Boyarsky, Michael T. Ou, William A. Werbel, Robin K. Avery, Aaron A.R. Tobian, Allan B. Massie, James P.A. Hamilton, Jacqueline M. Garonzik-Wang, Dorry L. Segev

School of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1852-1856
Number of pages	5
Journal	Liver Transplantation
Volume	27
Issue number	12
DOIs	https://doi.org/10.1002/lt.26273
State	Published - Dec 2021

ASJC Scopus subject areas

Surgery
Hepatology
Transplantation

Access to Document

10.1002/lt.26273

Cite this

Strauss, A. T., Hallett, A. M., Boyarsky, B. J., Ou, M. T., Werbel, W. A., Avery, R. K., Tobian, A. A. R., Massie, A. B., Hamilton, J. P. A., Garonzik-Wang, J. M., & Segev, D. L. (2021). Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients. Liver Transplantation, 27(12), 1852-1856. https://doi.org/10.1002/lt.26273

@article{3f38cd80383c4b00bc18fa577a7bc497,

title = "Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients",

author = "Strauss, {Alexandra T.} and Hallett, {Andrew M.} and Boyarsky, {Brian J.} and Ou, {Michael T.} and Werbel, {William A.} and Avery, {Robin K.} and Tobian, {Aaron A.R.} and Massie, {Allan B.} and Hamilton, {James P.A.} and Garonzik-Wang, {Jacqueline M.} and Segev, {Dorry L.}",

note = "Funding Information: This research was made possible with the generous support of the Ben-Dov family. This work was supported by Grants T32DK007732 (Andrew M. Hallett), F32DK124941 (Brian J. Boyarsky), K01DK101677 (Allan B. Massie), and K23DK115908 (Jacqueline M. Garonzik-Wang) from the National Institute of Diabetes and Digestive and Kidney Diseases; Grant K24AI144954 (Dorry L. Segev) from the National Institute of Allergy and Infectious Diseases; and a grant from the Transplantation and Immunology Research Network of the American Society of Transplantation (William A. Werbel). The analyses described here are the responsibility of the authors alone and do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. Funding Information: Dorry L. Segev has the following financial disclosures: consulting and/or speaking honoraria from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallinckrodt, and Thermo Fisher Scientific. Robin K. Avery has the following financial disclosures: study/grant support from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, and Takeda/Shire. The other authors of this manuscript have no financial disclosures to make. Funding Information: This research was made possible with the generous support of the Ben‐Dov family. This work was supported by Grants T32DK007732 (Andrew M. Hallett), F32DK124941 (Brian J. Boyarsky), K01DK101677 (Allan B. Massie), and K23DK115908 (Jacqueline M. Garonzik‐Wang) from the National Institute of Diabetes and Digestive and Kidney Diseases; Grant K24AI144954 (Dorry L. Segev) from the National Institute of Allergy and Infectious Diseases; and a grant from the Transplantation and Immunology Research Network of the American Society of Transplantation (William A. Werbel). The analyses described here are the responsibility of the authors alone and do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. ",

year = "2021",

month = dec,

doi = "10.1002/lt.26273",

language = "English (US)",

volume = "27",

pages = "1852--1856",

journal = "Liver Transplantation",

issn = "1527-6465",

publisher = "John Wiley and Sons Ltd",

number = "12",

}

TY - JOUR

T1 - Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients

AU - Strauss, Alexandra T.

AU - Hallett, Andrew M.

AU - Boyarsky, Brian J.

AU - Ou, Michael T.

AU - Werbel, William A.

AU - Avery, Robin K.

AU - Tobian, Aaron A.R.

AU - Massie, Allan B.

AU - Hamilton, James P.A.

AU - Garonzik-Wang, Jacqueline M.

AU - Segev, Dorry L.

N1 - Funding Information: This research was made possible with the generous support of the Ben-Dov family. This work was supported by Grants T32DK007732 (Andrew M. Hallett), F32DK124941 (Brian J. Boyarsky), K01DK101677 (Allan B. Massie), and K23DK115908 (Jacqueline M. Garonzik-Wang) from the National Institute of Diabetes and Digestive and Kidney Diseases; Grant K24AI144954 (Dorry L. Segev) from the National Institute of Allergy and Infectious Diseases; and a grant from the Transplantation and Immunology Research Network of the American Society of Transplantation (William A. Werbel). The analyses described here are the responsibility of the authors alone and do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. Funding Information: Dorry L. Segev has the following financial disclosures: consulting and/or speaking honoraria from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallinckrodt, and Thermo Fisher Scientific. Robin K. Avery has the following financial disclosures: study/grant support from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, and Takeda/Shire. The other authors of this manuscript have no financial disclosures to make. Funding Information: This research was made possible with the generous support of the Ben‐Dov family. This work was supported by Grants T32DK007732 (Andrew M. Hallett), F32DK124941 (Brian J. Boyarsky), K01DK101677 (Allan B. Massie), and K23DK115908 (Jacqueline M. Garonzik‐Wang) from the National Institute of Diabetes and Digestive and Kidney Diseases; Grant K24AI144954 (Dorry L. Segev) from the National Institute of Allergy and Infectious Diseases; and a grant from the Transplantation and Immunology Research Network of the American Society of Transplantation (William A. Werbel). The analyses described here are the responsibility of the authors alone and do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government.

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85114951838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114951838&partnerID=8YFLogxK

U2 - 10.1002/lt.26273

DO - 10.1002/lt.26273

M3 - Article

C2 - 34407309

AN - SCOPUS:85114951838

SN - 1527-6465

VL - 27

SP - 1852

EP - 1856

JO - Liver Transplantation

JF - Liver Transplantation

IS - 12

ER -

Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this